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Cases Controls p Value
Sample size 42 84
Median age 39 43
Male:female 37:5 36:2
At-risk individuals 9 (21%) 20 (24%)
Vaccinated pilgrims 9 (21%) 19 (23%)
Major symptoms
Sore throat 37 (88%) 67 (80%) 0.25
Cough 37 (88%) 59 (70%) 0.03
Subjective fever 32 (76%) 38 (45%) <0.01
Rhinorrhea 28 (67%) 61 (73%) 0.49
Myalgia 7 (17%) 12 (14%) 0.73
Diarrhea 4 (10%) 7 (8%) 0.82
Headache 0 (0%) 2 (2%) 0.31
Temperature 37.8 8C 13 (31%) 9 (11%) <0.01*Corresponding author
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Recent studies have challenged the Centers for Disease
Control and Prevention (CDC) definition of influenza-like
illness (ILI) as ‘temperature of 37.8 8C and either cough
or sore throat in the absence of a known cause other than
influenza’.1—3 We assessed the sensitivity and specificity of
this definition in identifying ILI at the Hajj, the yearly pilgrim-
age of Muslims to Mecca, Saudi Arabia, where an estimated
24 000 pilgrims suffer from influenza each year.4—6
During the Hajj 2005 and 2006, we recruited a total of 555
pilgrims with upper respiratory symptoms who presented at
our clinics in Mecca during the Hajj or attended local mos-
ques in the UK after the Hajj. After obtaining demographics,
symptoms and risk factors, we collected nasal swabs for PCR
analysis. Individuals with PCR-confirmed influenza were
selected as cases and the others as controls; two controls
per case were chosen by random numbers.7
Fifty-nine (11%) pilgrims had PCR-confirmed influenza;
with the exclusion of 17 incomplete entries, 42 of these
were ultimately selected as cases. Eighty-four controls were
randomly chosen (Table 1). Twelve (28%) cases met the CDC
criteria of ILI, however seven (8%) of the controls also met
these criteria ( p < 0.01) giving a sensitivity and specificity of
the CDC definition in identifying influenza of 28% (12/42) and92% (77/84), respectively. Its positive predictive value (PPV)
was 63% (12/19) and negative predictive value (NPV) was 72%
(77/107). The combination of cough, sore throat and sub-
jective fever applied to 28 (67%) cases and 30 (36%) controls
( p < 0.01), giving a sensitivity and specificity of this triad of
67% (28/42) and 64% (54/84), respectively. Its PPV was 48%
(28/58) and NPV was 79% (54/68).
As in this study, other studies have also demonstrated
the low sensitivity of the CDC criteria1 and have suggested
the triad of cough, subjective fever and fatigue to define
ILI;1—3 however fatigue was not reported by any of our
recruits, possibly because pilgrims expect to feel fatigue
as a result of strenuous Hajj rituals or as a travel-associated
symptom.8
A Canadian study showed that the probability of a positive
result of influenza increased with higher temperature,9 how-
ever recording temperature is not always practical at large
gatherings. Furthermore, its measurement may be influ-
enced by the route, thermometer type, phase of infection,
and antipyretic use.1,3 We suggest, therefore that the triad of
‘cough, sore throat and subjective fever’ is used to define ILI
at the Hajj or other mass gatherings (e.g., Olympic games,
FIFAWorld Cup), which is simple, specific and more sensitive
than the CDC definition.
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doi:10.1016/j.ijid.2007.03.009Figure 1 Axial FLAIR image through the posterior fossa demon-
strates high signal changes in the left cerebellar hemisphere
suggestive of edema. There is very little if any mass effect.A case of neurosyphilis involving the cerebel-
lum on magnetic resonance imaging (MRI) with
resolution of the abnormality after treatment
We report herein the case of a 77-year-old male with a history
of coronary artery disease, hypertension and hyperlipidemia,
who was transferred to our institution from an outside hos-
pital where he had been admitted several days previously
with a left occipital headache and intermittent fever. His
headache was dull in nature, graded 5/10, and associated
with intermittent fever of about two-months duration. He
also complained of night sweats of one and a half months
duration but denied nausea, vomiting or vertigo. His exam-
ination was unremarkable including no ataxia. Magnetic
resonance imaging (MRI) revealed a large area of signal
abnormality in the left cerebellar hemisphere on the T2
and FLAIR (fluid-attenuated inversion recovery) (Figure 1)
sequences, with thick, nodular meningeal enhancement in
the posterior fossa bilaterally (Figure 2), but more on the left
side. Additionally there was an area of localized restricted
diffusion in the cerebellar hemisphere on the left (Figure 3),
indicating cytotoxic injury. A diagnosis of meningoencepha-
litis was entertained. As part of fever work-up, he had a
serum syphilis test (RPR, rapid plasma reagin), which was
reactive at a dilution of 1:8; a syphilis confirmatory test —
TPPA (Treponema pallidum particle agglutination was posi-
tive as well. When the patient was further questioned in
private about his past history of syphilis, he mentioned that
he had had syphilis in the 1940s and had been treated with
penicillin (dose unknown) and bismuth as well as ‘other
treatments’ for a few months. Because of the suspicion of
neurosyphilis, he underwent a lumbar puncture. The cere-brospinal fluid (CSF) was clear and colorless; the white blood
cell count (WBC) was 22  106/l with 82% lymphocytes, 1%
polymorphonuclear lymphocytes (PMNs), and 17% monocytes.
The red blood cell count (RBC) was 21  106/l, CSF glucose
55 mg/dl, and protein 59 mg/dl. The CSF VDRL (venereal
disease research laboratory test) was non-reactive on August
